Cancer-Channel Icon 

The heterogeneity and complexity of malignant tumors has changed the way we think about the initiation, progression, diagnosis, and management of cancer. The Cancer Channel will explore the emerging molecular markers, improved preclinical models, genomic-based and immune-modulated therapies that are enabling precision oncology.

Cancer Molecular Markers


Circulating Tumor Cells


Cancer Immunotherapy - New


Predictive Preclinical Models in Oncology

 

You may also be interested in:

Symposia:

Circulating Cell-Free DNA

Biomarkers for Cancer Immunotherapy

 

Premier Sponsors:   

Elsevier    

Jackson Laboratory - small logo  

 NanoString2    

 Precision for Medicine 

SeraCare 

Silicon Biosystems 

Thomson Reuters-Large